Keywords: update, ligand, 1st-qtr, loss, deepens, usa, pharmaceuticals

UPDATE: Ligand's 1st-qtr 2009 loss deepens 30%

Article | 12 May 2009

Print This

The USA's Ligand Pharmaceuticals net loss in the first quarter of 2009 totaled $5.1 million, or $0.05 per share, versus a loss of $3.9 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in